Correlation Between Neurobiological Technologies and BioCardia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurobiological Technologies and BioCardia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobiological Technologies and BioCardia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobiological Technologies and BioCardia, you can compare the effects of market volatilities on Neurobiological Technologies and BioCardia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobiological Technologies with a short position of BioCardia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobiological Technologies and BioCardia.

Diversification Opportunities for Neurobiological Technologies and BioCardia

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Neurobiological and BioCardia is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neurobiological Technologies and BioCardia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioCardia and Neurobiological Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobiological Technologies are associated (or correlated) with BioCardia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioCardia has no effect on the direction of Neurobiological Technologies i.e., Neurobiological Technologies and BioCardia go up and down completely randomly.

Pair Corralation between Neurobiological Technologies and BioCardia

If you would invest  2.61  in BioCardia on October 7, 2024 and sell it today you would lose (2.61) from holding BioCardia or give up 100.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy1.2%
ValuesDaily Returns

Neurobiological Technologies  vs.  BioCardia

 Performance 
       Timeline  
Neurobiological Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neurobiological Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward indicators, Neurobiological Technologies is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
BioCardia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioCardia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BioCardia is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Neurobiological Technologies and BioCardia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurobiological Technologies and BioCardia

The main advantage of trading using opposite Neurobiological Technologies and BioCardia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobiological Technologies position performs unexpectedly, BioCardia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCardia will offset losses from the drop in BioCardia's long position.
The idea behind Neurobiological Technologies and BioCardia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data